Abstract:To date, the epigenetic signature of preeclampsia (PE) is not completely deciphered. Oxidative stress-responsive long non-coding RNAs (lncRNAs) are deregulated in preeclamptic placenta; however, their circulating profiles and diagnostic abilities are still unexplored. We investigated serum redox-sensitive lncRNAs TUG1, H19, and NEAT1, and their target miR-29b/cystine/neutral/dibasic amino acids transporter solute carrier family 3, member 1 (SLC3A1) as potential non-invasive biomarkers of PE risk, onset, and severity. We recruited 82 patients with PE and 78 healthy pregnant women. We classified PE patients into early-onset (EOPE) and late-onset (LOPE) subgroups at a cut-off 34 gestational weeks and into severe and mild PE subgroups by blood pressure and proteinuria criteria. Bioinformatics analysis was employed to select lncRNAs/microRNA/target gene interactions. Serum H19, NEAT1, and SLC3A1 mRNA expression were reduced, meanwhile miR-29b levels were elevated, whereas there was no significant difference in TUG1 levels between PE patients and healthy pregnancies. Serum H19 levels were lower, whereas miR-29b levels were higher in EOPE versus LOPE. Serum miR-29b and H19 levels were higher in severe versus mild PE. ROC analysis identified serum H19, NEAT1, miR-29b, and SLC3A1 as potential diagnostic markers, with H19 (AUC = 0.818, 95%CI = 0.744-0.894) and miR-29b (AUC = 0.82, 95%CI = 0.755-0.885) were superior discriminators. Only H19 and miR-29b discriminated EOPE and severe PE cases. In multivariate logistic analysis, miR-29b and H19 were associated with EOPE, using maternal age and gestational age as covariates, while miR-29b was associated with severe PE, using maternal age as covariate. Studied markers were correlated with clinical and ultrasound data in the overall PE group. Serum H19 and TUG1 were negatively correlated with albuminuria in EOPE and LOPE, respectively. NEAT1 and SLC3A1 were correlated with ultrasound data in EOPE. Likewise, TUG1, miR-29b, and SLC3A1 showed significant correlations with ultrasound data in LOPE. Conclusively, this study configures SLC3A1 expression as a novel potential serum biomarker of PE and advocates serum H19 and miR-29b as biomarkers of EOPE and miR-29b as a biomarker of PE severity.

Quantification of Preeclampsia-Related Micrornas in Maternal Serum.

Study on the differential expression of microRNAs in the preeclampsia serum

Bioinformatics-based Identification of Mirna-, Lncrna-, and Mrna-Associated Cerna Networks and Potential Biomarkers for Preeclampsia.

Differential Expression Of Micrornas In The Placentae Of Chinese Patients With Severe Pre-Eclampsia

Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects.

Variations of MicroRNAs in Human Placentas and Plasma from Preeclamptic Pregnancy

Integrated analysis of microRNA and mRNA expression profiles in Preeclampsia

Uncovering serum placental-related non-coding RNAs as possible biomarkers of preeclampsia risk, onset and severity revealed MALAT-1, miR-363 and miR-17

Identification of differentially expressed miRNAs in plasma exosomes from patients with early-onset pre-eclampsia using next generation sequencing

Circulating Micrornas As Biomarkers for Diagnosis and Prediction of Preeclampsia: A Systematic Review and Meta-Analysis

Serum lncRNAs TUG1, H19, and NEAT1 and their target miR-29b/SLC3A1 axis as possible biomarkers of preeclampsia: Potential clinical insights

Placental Mir-106A∼363 Cluster is Dysregulated in Preeclamptic Placenta.

miR-31-5p from placental and peripheral blood exosomes is a potential biomarker to diagnose preeclampsia

The aberrantly expressed miR-193b-3p contributes to preeclampsia through regulating transforming growth factor-β signaling

Profiling of Exosomal Micrornas Expression in Umbilical Cord Blood from Normal and Preeclampsia Patients

Placenta-derived exosomes as carriers of non-coding RNAs in maternal circulation of patients with preeclampsia

Elevated Placental microRNA-155 Is a Biomarker of a Preeclamptic Subtype

Circulating extracellular vesicular microRNA signatures in early gestation show an association with subsequent clinical features of pre-eclampsia

Placental expressions of Anti-Mullerian hormone/Receptor, vascular endothelial growth factor and related microRNAs in patients with preeclampsia: a case control study

Serum markers of pre-eclampsia identified on proteomics.

Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia